Chronic Thromboembolic Pulmonary Hypertension
Ehtisham Mahmud(Cardiovascular Institute of the South), William R. Auger(University of California System), Nick H. Kim(University of California San Diego), Omid Behnamfar, David Poch(University of California System), Michael M. Madani(University of California San Diego), Lawrence Ang(University of California San Diego), Mitul Patel(University of California San Diego)
Cited by 170
Related Papers
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
|New England Journal of Medicine|2013|1.4k
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
|Journal of the American College of Cardiology|2020|395
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women
|Circulation|2020|310
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)
|European Respiratory Journal|2014|309